Continued uncertainty regarding treatment of patent ductus arteriosus in premature infants and the role of clinical trials

Despite several decades of research into treatments for patent ductus arteriosus (PDA), there is continued uncertainty regarding whether, when, and how best to treat PDA and the long-term consequences. There are almost 5000 babies enrolled into clinical trials, but the questions remain largely unans...